SPYRE THERAPEUTICS, INC. (SYRE)

SEC filing

SPYRE THERAPEUTICS, INC.

SYRE · CIK 1636282

4 · Oct 2, 2026 · See Remarks King-Jones Heidy sold 28.93K shares at $91.03/share ($2.6M); exercised options for 57.87K shares

See Remarks King-Jones Heidy sold 28.93K shares at $91.03/share ($2.6M); exercised options for 57.87K shares

FORM 4

xslF345X06/wk-form4_1790991012.xmlSEC.gov

Graphics and non-inline formats (not embedded below).